Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Alpha-1D adrenergic receptor | ||
| Ligand | BDBM50211341 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_444278 (CHEMBL894518) | ||
| Ki | 0.14±n/a nM | ||
| Citation |  Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA (Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS). Bioorg Med Chem Lett17:3292-7 (2007) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Alpha-1D adrenergic receptor | |||
| Name: | Alpha-1D adrenergic receptor | ||
| Synonyms: | ADA1D_HUMAN | ADRA1A | ADRA1D | Adrenergic receptor | Adrenergic receptor alpha | Alpha 1D-adrenoceptor | Alpha 1D-adrenoreceptor | Alpha adrenergic receptor (1a and 1d) | Alpha-1D adrenoceptor | Alpha-adrenergic receptor 1a | adrenergic Alpha1D | ||
| Type: | Enzyme Catalytic Domain | ||
| Mol. Mass.: | 60485.82 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | adrenergic Alpha1D ADRA1D HUMAN::P25100 | ||
| Residue: | 572 | ||
| Sequence: |
| ||
| BDBM50211341 | |||
| n/a | |||
| Name | BDBM50211341 | ||
| Synonyms: | 5-bromo-6-chloro-N-((1s,4s)-4-(4-(2-isopropoxyphenyl)piperazin-1-yl)cyclohexyl)pyridine-3-sulfonamide | CHEMBL232609 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C24H32BrClN4O3S | ||
| Mol. Mass. | 571.958 | ||
| SMILES | CC(C)Oc1ccccc1N1CCN(CC1)[C@@H]1CC[C@@H](CC1)NS(=O)(=O)c1cnc(Cl)c(Br)c1 |wU:16.17,19.24,(-7.75,-8.21,;-8.54,-9.53,;-10.08,-9.51,;-7.79,-10.88,;-8.57,-12.2,;-10.11,-12.18,;-10.9,-13.51,;-10.14,-14.86,;-8.6,-14.87,;-7.82,-13.55,;-6.29,-13.56,;-5.53,-14.9,;-3.99,-14.92,;-3.21,-13.6,;-3.95,-12.26,;-5.49,-12.24,;-1.67,-13.62,;-.92,-14.97,;.61,-14.99,;1.41,-13.67,;.65,-12.32,;-.89,-12.3,;2.96,-13.7,;3.74,-12.37,;2.41,-11.59,;5.06,-13.14,;4.5,-11.03,;6.05,-11.02,;6.8,-9.68,;6.02,-8.35,;6.78,-7.01,;4.47,-8.37,;3.69,-7.05,;3.72,-9.71,)| | ||
| Structure | 
| ||